| For Practicing Oncologists |
See all
|
Article Summary
|
|
|
Sehouli J et al. - Nonplatinum topotecan combinations do not provide a survival advantage over topotecan alone in women with relapsed ovarian cancer.
|
 |
|
|
| Sponsor |
|
 |
| Read a Different Specialty |
 |
|
|
|
 |
| Profession Index |
 |
|
|
|
 |
|
|
|
| Sponsor |
|
|
| Sponsor |
|